Status:

ACTIVE_NOT_RECRUITING

A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Lead Sponsor:

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Conditions:

Myopia

Eligibility:

All Genders

6-10 years

Phase:

PHASE3

Brief Summary

This study was a randomized, double-blind, placebo-controlled, multicenter, superiority design, phase III clinical trial to compare the efficacy and safety of two low-concentration atropine sulfate ey...

Detailed Description

Eligible subjects were screened and randomly assigned to the placebo control group, the lower dose group, and the lower dose group. Subjects received the study drug in both eyes, 1 drop each time, onc...

Eligibility Criteria

Inclusion

  • Child (female or male) aged 6 to 10 years.
  • Myopia (SER of at least -0.50 D and no more myopic than -6.00 D) in each eye as measured by cycloplegic autorefraction.
  • If present, astigmatism of ≤1.50 D in each eye as measured by cycloplegic autorefraction.
  • Anisometropia SER of \< 1.50 D as measured by cycloplegic autorefraction.

Exclusion

  • History of any disease or syndrome that predisposed the subject to severe myopia (e.g.,Marfan syndrome, Stickler syndrome, retinopathy of prematurity).
  • History in either eye of abnormal ocular refractive anatomy (e.g., keratoconus, lenticonus,spherophakia).
  • Chronic use of any topical or systemic antimuscarinic/anticholinergic medications (e.g.,atropine, scopolamine, tropicamide) within 21 days prior to screening and/or anticipated need for chronic use during the study period (i.e., more than 7 consecutive days in 1 month or more than 30 total days in 1 year).
  • Use of cycloplegic drops for dilated ocular exam was allowable.
  • Heart rate persistently (for more than 10 minutes) \> 120 beats per minute.
  • Allergy to study drugs.

Key Trial Info

Start Date :

May 13 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2025

Estimated Enrollment :

526 Patients enrolled

Trial Details

Trial ID

NCT06209281

Start Date

May 13 2022

End Date

December 1 2025

Last Update

July 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Eye & ENT Hospital of Fudan University

Shanghai, Shanghai Municipality, China